Balaji Olety Amaranath

Research & Development
Balaji Olety Amaranath

Balaji is a principal scientist and team leader overseeing the Merck-Dewpoint collaboration on HIV.

Balaji is a trained cell-molecular biologist who completed his doctorate work on unconventional myosins. Subsequently, he studied mechanisms of viral assembly and host-virus interactions at the University of Michigan Ann Arbor and the University of Massachusetts Medical School, respectively.

Balaji has broad experience in diverse biochemical and cell-based assays, preclinical proof of concept studies and leading projects in early-stage drug discovery.

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
© 2019-2023 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science